{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:04:54Z","timestamp":1780031094392,"version":"3.53.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003454","name":"Guangxi Zhuang Autonomous Region Health Department","doi-asserted-by":"publisher","award":["Z-K20231763"],"award-info":[{"award-number":["Z-K20231763"]}],"id":[{"id":"10.13039\/501100003454","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Origin Recognition Complex Subunit 6 (\n                      <jats:italic>ORC6<\/jats:italic>\n                      ) is essential for DNA replication initiation. However, its dynamic expression patterns and potential biological functions during the progression of cervical lesions remain unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analyzed the differential expression of\n                      <jats:italic>ORC6<\/jats:italic>\n                      in cervical cancer and normal tissues using an integrated TCGA-GTEx-CESC dataset and explored its potential regulatory mechanisms via GO\/KEGG, GSEA, and CIBERSORT immune infiltration analyses. Furthermore, a total of 163 clinical tissue specimens (including CIN I, CIN II, CIN III, and invasive cervical carcinoma) were examined by immunohistochemistry (IHC) to evaluate\n                      <jats:italic>ORC6<\/jats:italic>\n                      protein expression and its association with pathological grade and clinicopathological characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Bioinformatics analysis revealed that\n                      <jats:italic>ORC6<\/jats:italic>\n                      was significantly upregulated in cervical cancer (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001) and was associated with transcriptional programs related to E2F targets, DNA replication, and the G2\/M checkpoint. Immune infiltration analysis showed that elevated\n                      <jats:italic>ORC6<\/jats:italic>\n                      expression was associated with a distinct immune infiltration pattern, characterized by increased M0 macrophages and reduced activated NK cells, resting NK cells, and CD8+ T cells. IHC analysis further demonstrated that\n                      <jats:italic>ORC6<\/jats:italic>\n                      expression was significantly increased in cervical lesions and invasive carcinoma compared with normal cervical tissues (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;\u00a00.001). Notably,\n                      <jats:italic>ORC6<\/jats:italic>\n                      expression was significantly higher in the CIN II\u2013III group than in the CIN I group (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;\u00a00.01). In contrast,\n                      <jats:italic>ORC6<\/jats:italic>\n                      expression was not significantly associated with tumor differentiation, lymph node metastasis, vascular invasion, perineural invasion, or overall survival (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>ORC6<\/jats:italic>\n                      is closely associated with the progression of HPV-related cervical lesions, particularly the transition from CIN I to CIN II\u2013III.\n                      <jats:italic>ORC6<\/jats:italic>\n                      may serve as a potential auxiliary biomarker for the identification and early stratification of high-grade squamous intraepithelial lesions (HSIL).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1795793","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:47:03Z","timestamp":1780030023000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["ORC6 drives the malignant progression of cervical squamous intraepithelial lesions and serves as a biomarker for high-grade dysplasia"],"prefix":"10.3389","volume":"16","author":[{"given":"Rouyi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pathology, The First People\u2019s Hospital of Yulin","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First People\u2019s Hospital of Yulin","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First People\u2019s Hospital of Yulin","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First People\u2019s Hospital of Yulin","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First People\u2019s Hospital of Yulin","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyan","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First People\u2019s Hospital of Yulin","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First People\u2019s Hospital of Yulin","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First People\u2019s Hospital of Yulin","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32470-x","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt235","article-title":"Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study","volume":"105","author":"Ikenberg","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20130036","article-title":"The origin recognition complex in human diseases","volume":"33","author":"Shen","year":"2013","journal-title":"Biosci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"103675\u2013","DOI":"10.1016\/j.critrevonc.2022.103675","article-title":"Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies","volume":"174","author":"Bhattacharjee","year":"2022","journal-title":"Crit Rev Oncology\/Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072802","article-title":"ORC6 involved in DNA replication, chromosome segregation, and cytokinesis","volume":"297","author":"Prasanth","year":"2002","journal-title":"Sci (New York NY)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa751","article-title":"Structural basis of DNA replication origin recognition by human ORC6 protein binding with DNA","volume":"48","author":"Xu","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121406119","article-title":"ORC6 is a component of the replication fork and enables efficient mismatch repair","volume":"119","author":"Lin","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12885-023-10763-z","article-title":"ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis","volume":"23","author":"Lin","year":"2023","journal-title":"BMC Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1236806\u2013","DOI":"10.3389\/fimmu.2023.1236806","article-title":"Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and Malignant progression","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.69344","article-title":"Over-activation of minichromosome maintenance protein 10 promotes genomic instability in early stages of breast cancer","volume":"18","author":"Mughal","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"323\u2013","DOI":"10.1186\/s40001-023-01246-9","article-title":"Exosomal NOX1 promotes tumor-associated macrophage M2 polarization-mediated cancer progression by stimulating ROS production in cervical cancer: a preliminary study","volume":"28","author":"Gu","year":"2023","journal-title":"Eur J Med Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400281r","article-title":"KIF23 promotes cervical cancer progression via inhibiting NLRP3-mediated pyroptosis","volume":"38","author":"Liu","year":"2024","journal-title":"FASEB Jour: Off Publ Fed Am Societies For Exp Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjy063","article-title":"Assembly of a parts list of the human mitotic cell cycle machinery","volume":"11","author":"Giotti","year":"2019","journal-title":"J Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16086\u2013","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7150\/jca.71313","article-title":"ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma","volume":"13","author":"Pan","year":"2022","journal-title":"J Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100403\u2013","DOI":"10.1016\/j.modpat.2023.100403","article-title":"Novel 2 gene signatures associated with breast cancer proliferation: Insights from predictive differential gene expression analysis","volume":"37","author":"Ibrahim","year":"2024","journal-title":"Modern Pathol: Off J United States Can Acad Pathol Inc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.652292","article-title":"ORC6, negatively regulated by miR-1-3p, promotes proliferation, migration, and invasion of hepatocellular carcinoma cells","volume":"9","author":"Chen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"96\u2013","DOI":"10.1016\/j.modpat.2023.100403","article-title":"ORC6 acts as an effective prognostic predictor for non-small cell lung cancer and is closely associated with tumor progression","volume":"27","author":"Chen","year":"2024","journal-title":"Oncol Lett"},{"key":"B22","doi-asserted-by":"publisher","first-page":"40852\u2013","DOI":"10.1109\/ias.2006.256860","article-title":"High ORC6 expression is a prognostic indicator of poor survival in glioma patients","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3116\u2013","DOI":"10.3389\/fmicb.2019.03116","article-title":"Human papillomavirus E6 and E7: The cervical cancer hallmarks and targets for therapy","volume":"10","author":"Pal","year":"2020","journal-title":"Front Microbiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3295","article-title":"Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer","volume":"10","author":"Song","year":"2015","journal-title":"Oncol Lett"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/biology13020077","article-title":"The hallmarks of cervical cancer: Molecular mechanisms induced by human papillomavirus","volume":"13","author":"Rosendo-Chalma","year":"2024","journal-title":"Biology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1795793\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:47:09Z","timestamp":1780030029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1795793\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":25,"alternative-id":["10.3389\/fonc.2026.1795793"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1795793","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1795793"}}